STOCKSCREENR

0J4V.L

LSE

Heron Therapeutics, Inc.

$1.20+0.03(+2.73%)Mkt Cap: $200.42M

Key Stats

Market Cap

$200.42M

P/E Ratio

-0.52

EPS

$-2.29

Dividend Yield

0.00%

52-Week Range

$0.54 — $3.19

Volume

81.00K

Avg Volume

12.41K

Beta

1.42

Price Alerts for 0J4V.L

Get alerted when 0J4V.L hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

-0.52

Forward P/E

24.04

PEG Ratio

0.16

P/S (TTM)

1.02

P/B (TTM)

11.63

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

3.05%

ROA (TTM)

-0.08%

ROIC

—

Gross Margin

0.73%

Operating Margin

-0.02%

Net Margin

—

Debt/Equity

9.81

Current Ratio

2.48

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+0.55%

EPS Growth (5Y)

+0.35%

Sales Growth (3Y)

+0.19%

Sales Growth (5Y)

+0.03%

EPS Est (This Year)

$0.05

EPS Est (Next Year)

$0.12

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.28

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

157.94M

Float

132.04M

Free Float %

83.60%

About

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Country

US

Exchange

LSE

IPO Date

2018-01-29

Employees

122

CEO

Craig Alexander Collard

Index Membership

—

Website

https://www.herontx.com

Heron Therapeutics, Inc. (0J4V.L) is a healthcare company in the medical - pharmaceuticals industry listed on the LSE. With a market capitalization of $200.42M, a P/E ratio of -0.52, 0J4V.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 0J4V.L against other stocks using dozens of fundamental and technical filters.

Similar Stocks

ATAI

Atai Beckley N.V

$4.16

+0.97%

$784.68M

0DOL.L

Biofrontera AG

$2.50

+1.63%

$111.43M

LFMD

LifeMD, Inc.

$4.68

+5.64%

$224.52M

0RNK.L

Inventiva S.A.

$4.27

+1.67%

$593.11M

0LOV.L

Verastem, Inc.

$5.42

+2.07%

$328.12M

0DTF.L

Boiron S.A.

$26.10

-1.14%

$453.16M

Frequently Asked Questions

What is Heron Therapeutics, Inc.'s P/E ratio?

Heron Therapeutics, Inc. (0J4V.L) has a trailing twelve-month (TTM) P/E ratio of -0.52. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Heron Therapeutics, Inc. pay a dividend?

No, Heron Therapeutics, Inc. (0J4V.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Heron Therapeutics, Inc.'s market cap?

Heron Therapeutics, Inc. (0J4V.L) has a market capitalization of $200.42 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.